IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $283,004 | -4.4% | 155,497 | +166.2% | 0.00% | – |
Q4 2022 | $296,123 | -21.0% | 58,407 | -22.5% | 0.00% | – |
Q3 2022 | $375,000 | +66.7% | 75,369 | +24.6% | 0.00% | – |
Q2 2022 | $225,000 | -93.7% | 60,472 | -75.8% | 0.00% | -100.0% |
Q2 2021 | $3,571,000 | -51.6% | 250,096 | -19.6% | 0.00% | -55.6% |
Q1 2021 | $7,381,000 | – | 310,920 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |